HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.

AbstractOBJECTIVES:
The aims of this study were to identify the incidence of hemoglobinopathies and thalassemias in Northern Alberta and calculate the reference intervals (RI) for hemoglobin (Hb) HbF and HbA2.
METHODS:
A retrospective ad-hoc analysis of the structural Hb variants and thalassemias identified on patients who had a hemoglobinopathy/thalassemia investigation performed between February 1 to December 31, 2013. Results were extracted from the Laboratory Information System. Statistical analysis was performed using MedCalc® version 11.4.2.0 for Windows software.
RESULTS:
6616 hemoglobinopathy/thalassemia investigations and HbS screens were physician requested and 602 Hb variants were fortuitously found during HbA1c analysis. 3438 were interpreted as "normal" and 532 were classified as iron deficient. 3306 individuals, with age ranging from 3 to 92 years were included in the RI calculation. HbA2 RI was 2.3% to 3.4% and HbF 0.0% to 1.8%. 524 and 423 α and β thalassemia traits respectively were identified. Additionally ten δβ thalassemia traits and twelve cases of HbH disease were identified. Regarding hemoglobinopathies, 7% were classified as α-chain variants and 93% as β-chain variants with HbS (46%), HbE (16%), HbD Punjab (8%) and HbC (7%) traits being the most prevalent. We also documented 20 homozygous hemoglobinopathies and 36 compound/double heterozygous hemoglobinopathies.
CONCLUSION:
A wide diversity of hemoglobinopathies is found in the Northern Alberta population, 80% of the hemoglobinopathies were found as a reflex to HbA1c testing. Reference intervals for HbF and HbA2 were established.
AuthorsKarina Rodriguez-Capote, Trefor N Higgins
JournalClinical biochemistry (Clin Biochem) Vol. 48 Issue 10-11 Pg. 698-702 (Jul 2015) ISSN: 1873-2933 [Electronic] United States
PMID25869492 (Publication Type: Journal Article)
CopyrightCopyright © 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Hemoglobin A2
  • Fetal Hemoglobin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alberta (epidemiology)
  • Child
  • Child, Preschool
  • Female
  • Fetal Hemoglobin (metabolism)
  • Hemoglobin A2 (metabolism)
  • Hemoglobinopathies (blood, diagnosis, epidemiology)
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Reference Standards
  • Retrospective Studies
  • Thalassemia (blood, diagnosis, epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: